In FY 2025-26 highlights, total revenues for FY 2025-26 stood at INR 17,539.57-lakh on a standalone basis, up 7.74% from INR 16,280.01-lakh in FY 2024-25.
PBT surged 50.24% to INR 954.92-lakh in FY 2025-26 on a standalone basis (consolidated: INR 953.18-lakh, up 50.44%). PAT grew strongly by 55.63% to INR 691.96-lakh on a standalone basis (consolidated: INR 690.22-lakh, up 55.99%). EPS expanded 41.70% to INR 3.84 on both standalone and consolidated basis (FY25: INR 2.71 standalone / INR 2.70 consolidated).
The Board of Directors has recommended a dividend of 8% â Re 0.80 per equity share of face value of INR 10 each, for the financial year ended 31 March 2026, subject to shareholder approval at the 54th AGM.
During the year, the company has allotted 13,05,400 shares of INR 10 each at an issue price of INR 211 each by way of preferential allotment on private placement basis. The EPS has been calculated on a weighted average method.
Vipul P Shah, managing director, Vipul Organics, said, âFY 2025-26 has been a landmark year for Vipul Organics. Despite the headwinds posed by the ongoing conflict in the Middle East, which disrupted global shipping lanes and caused delays in certain export shipments, we have delivered our strongest financial performance to date, with PAT growing over 55% and PBT over 50% on a standalone basis. Within the country, our operations remained robust, and our cost optimisation initiatives continued to yield results. The Greenfield facility at Sayakha, Gujarat, is progressing well, and we expect it to contribute to both capacity and revenue diversification in the coming year. With our expanded product mix, a growing global client base across 45+ countries, and improved operational efficiencies, we enter FY 2026-27 with confidence.â